Genscript Biotech Corporation (GNNSF)

Genscript Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,893	2,716	5,398	6,741	9,297	2,842
Market Cap Growth	4.39%	-49.68%	-19.93%	-27.49%	227.16%	-33.34%
Enterprise Value	4,506	2,434	4,867	6,114	8,303	1,914
Last Close Price	2.20	1.27	2.44	2.96	4.55	1.41
PE Ratio	1.57	0.92	-	-	-	-
PS Ratio	5.91	4.57	9.63	10.77	18.97	7.27
PB Ratio	1.11	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	1.11	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	9805.94	-	-	-	-	-
P/OCF Ratio	21.42	35.90	-	-	-	-
EV/Sales Ratio	5.40	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	153.19	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	9029.77	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.11	8.51	8.59	-	-	-
Debt / FCF Ratio	1099.24	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Capital (ROIC)	2.88%	0.15%	0.67%	-14.32%	-17.72%	-20.18%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-	-	-
Earnings Yield	63.59%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	0.01%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.